Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7250383 | 1.00 | ADRB3 (0.43) | ADRB3ADRA1A | |
| SCHEMBL7111828 | 0.93 | ADRB3 (0.42) | ADRB3ADRA1A | |
| SCHEMBL7113359 | 0.93 | ADRB3 (0.42) | ADRB3ADRA1A | |
| SCHEMBL7111831 | 0.93 | ADRB3 (0.42) | ADRB3ADRA1A | |
| SCHEMBL7980808 | 0.87 | ADRB3 (0.39) | ADRB3ADRA1A | |
| SCHEMBL7980812 | 0.87 | ADRB3 (0.39) | ADRB3ADRA1A | |
| SCHEMBL7256258 | 0.85 | ADRB3 (0.57) | ADRB3ADRA1A | |
| SCHEMBL7256255 | 0.85 | ADRB3 (0.57) | ADRB3ADRA1A | |
| Hydrochloric Acid SCHEMBL7251267 | 0.84 | ADRB3 (0.56) | ADRB3ADRA1A | |
| Hydrochloric Acid SCHEMBL7251270 | 0.84 | ADRB3 (0.56) | ADRB3ADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030040538-A1 | Novel substituted tricyclic compounds | ASAHI-KASEI KABUSHIKI KAISHA (JP) | 2003-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030040538-A1 | Novel substituted tricyclic compounds | CPT1A, CBR1, NR1H3 | ADRB3 442/4885ADRA1A 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.